• February 15, 2010
    LAS VEGAS--Pfizer Animal Health today announced that the U.S. Food and Drug Administration (FDA) has approved EXCEDE® Sterile Suspension as the first safe and effective, long-acting antibiotic formulation licensed for horses. EXCEDE Sterile Suspension is the newest addition to Pfizer Animal Health’s extensive portfolio of equine products backed by scientific research and innovation in the field of equine medicine. EXCEDE Sterilemore...
  • February 8, 2010
    TOKYO--Pfizer Animal Health today announced it will begin to expand Japanese veterinary experience with IMPROVAC, Pfizer’s successful pork production technology embraced by pig farmers in other countries for more than 10 years. The Japanese Ministry of Agriculture Forestry and Fishery (JMAFF) has approved IMPROVAC as safe and effective for use by veterinarians in pigs throughout Japan. "In the months ahead, the experience gained withmore...
  • January 14, 2010
    KALAMAZOO, Mich.--A significant milestone in the history of beef genetics occurred today when Pfizer Animal Genetics announced the completion of HD 50K, the beef industry’s first commercially available predictions based on a High- Density panel of more than 50,000 markers. This breakthrough represents significantly greater selection opportunities for owners of black Angus cattle. “Pfizer Animal Genetics is very proud to bring a High-more...
  • January 28, 2009
    DURHAM, N.C.--An ever-growing world population, coupled with increasing feed costs and production pressures, will make demands on the global poultry industry greater than ever in years ahead. Poised to meet those demands is the Poultry Health Division of Pfizer Animal Health (PPH), a hybrid of engineering and poultry animal health technology and innovation that was born via the acquisition of Embrex, Inc. by Pfizer Animal Health in 2007more...